Frequency of celiac disease in patient with irritable bowel syndrome
Keywords:
frequency, celiac diseases, irritable bowel syndromeAbstract
Background: One of the most prevalent functional gastrointestinal illnesses is irritable bowel syndrome (IBS), which causes a variety of gastrointestinal symptoms, including changed bowel habits and stomach pain or discomfort, without an underlying basis. Objective: To assess the frequency of celiac disease in patient with irritable bowel syndrome. Methodology: This cross sectional study was carried out at the department of gastroenterology, Lady Reading Hospital Peshawar. The duration of study was two years from January 2018 to December 2019. The serological tests for celiac disease like IgA anti TTG and IgG anti TTG was determined. Biopsies were taken on upper gastrointestinal endoscopy. Data was collected in a specialized proforma for our research. All the data collected was analyzed by employing IBM SPSS version 23. Results: In our study, a total of 240 patients with irritable bowel syndrome were enrolled. Gender wise distribution shows that there were 132 (55%) male patients while the female patients were 108 (45%). The mean age of patients (SD) was 26.72 (± 2.27) years. The frequency of celiac disease based on serological testing was 20 (8.33%). The frequency of celiac disease based on histological findings was 15 (6.25%).
Downloads
References
Akhondi-Meybodi M, Rabei A, Salehi S. Frequency of Celiac Disease in Irritable Bowel Syndrome Patients with Predominant Diarrhea Referred to Gastroenterology Clinics in Yazd, Iran. J Shahid Sadoughi Univ Med Sci Health Services. 2012;12:64-8.
Al Attas RA. How common is celiac disease in Eastern Saudi Arabia? Ann Saudi Med. 2002;22(5-6):315-9.
Al-Ajlan AS. Screening of coeliac disease in undetected adults and patients diagnosed with irritable bowel syndrome in Riyadh, Saudi Arabia. Saudi J Biol Sci. 2016;23(4):462-6.
Al-Tawaty AI, Elbargathy SM. Coeliac disease in north-eastern Libya. Ann Trop Paediatr. 1998;18(1):27-30.
Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza G. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. The American journal of gastroenterology. 1999;94(3):691-6.
Cañón M, Ruiz AJ, Rondón M, Alvarado J. Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey. Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology. 2017;30(1):67.
Cash BD, Rubenstein JH, Young PE, Gentry A, Nojkov B, Lee D, et al. The prevalence of abnormal celiac antibodies and celiac disease in patients with suspected irritable bowel syndrome: a prospective multi-center US study. Gastroenterology. 2011;141(4):1187.
Catassi C, Fabiani E, Rätsch I, Coppa G, Giorgi P, Pierdomenico R, et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school‐age subjects. Acta Paediatr. 1996;85:29-35.
Catassi C, Ratsch I-M, Gandolfi L, Pratesi R, Fabiani E, El Asmar R, et al. Why is coeliac disease endemic in the people of the Sahara? The Lancet. 1999;354(9179):647-8.
Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949-58.
Chowdhury M, Chakraborty R, Gope S, Rahman M, Miah A, Raihan A, et al. Celiac Disease in Patients Fulfilling the Rome III Criteria for Irritable Bowel Syndrome Attending Gastroenterology Department of A Tertiary Care Hospital in Bangladesh. Mymensingh Medical Journal: MMJ. 2016;25(1):102-8.
Demir E, Comba A. The evolution of celiac disease publications: a holistic approach with bibliometric analysis. Irish Journal of Medical Science (1971-). 2020;189:267-76.
Domżał-Magrowska D, Kowalski MK, Szcześniak P, Bulska M, Orszulak-Michalak D, Małecka-Panas E. The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes. Gastroenterology Review/Przegląd Gastroenterologiczny. 2016;11(4):276-81.
Drossman DA. Rome II. The functional gastrointestinal disorders, diagnosis, pathophusiology and treatment: A multinational consensus. 2000.
Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128(4):S57-S67.
El-Metwally A, Toivola P, AlAhmary K, Bahkali S, AlKhathaami A, AlSaqabi MK, et al. The epidemiology of celiac disease in the general population and high-risk groups in Arab countries: a systematic review. BioMed research international. 2020;2020.
Emami MH, Karimi S, Kouhestani S, Hashemi M, Taheri H. Diagnostic accuracy of IgA anti-tissue transglutaminase in patients suspected of having coeliac disease in Iran. J Gastrointestin Liver Dis. 2008;17(2):141-6.
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163(3):286-92.
Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran's gastrointestinal and liver disease E-book: pathophysiology, diagnosis, management: Elsevier health sciences; 2020.
Green PH, Stavropoulos SN, Panagi SG, Goldstein SL, McMahon DJ, Absan H, et al. Characteristics of adult celiac disease in the USA: results of a national survey. The American journal of gastroenterology. 2001;96(1):126-31.
Hellström PM, Benno P. The Rome IV: irritable bowel syndrome-a functional disorder. Best Practice & Research Clinical Gastroenterology. 2019;40:101634.
Jadallah KA, Khader YS. Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study. World Journal of Gastroenterology: WJG. 2009;15(42):5321.
Khan IM, Hassan MK, Rahman S, Javed M, Khattak AK, Hameed K, et al. Frequency of organic pathologies in patients with irritable bowel syndrome. Journal of Postgraduate Medical Institute. 2009;23(4).
Khan KU, Ifithikhar M, Khan I, Khan A, Khan MZ, Amin S. THE FREQUENCY OF CELIAC DISEASES AMONG PATIENT WITH SUSPECTED IRRITABLE BOWEL SYNDROME, A CROSS SECTIONAL INSTITUTED BASED STUDY. KJMS. 2019;12(2):247.
Kim YS, Kim N. Functional dyspepsia: a narrative review with a focus on sex-gender differences. J Neurogastroenterol Motil. 2020;26(3):322.
Lindfors K, Ciacci C, Kurppa K, Lundin KE, Makharia GK, Mearin ML, et al. Coeliac disease. Nature Reviews Disease Primers. 2019;5(1):3.
Lo W, Sano K, Lebwohl B, Diamond B, Green PH. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395-8.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712-21. e4.
Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PH, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52.
Mahmoodi A, Jafarihaydarlo A, Yasemi M, Hemati K, Peyman H. Celiac disease prevalence in the patients with irritable bowel syndrome in the Ilam province; a cross sectional study from Western Iran. Journal of clinical and diagnostic research: JCDR. 2014;8(12):GC01.
Makharia GK, Baba CS, Khadgawat R, Lal S, Tevatia M, Madan K, et al. Celiac disease: variations of presentations in adults. Indian J Gastroenterol. 2007;26(4):162.
Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm. 2013;19(9):755-64.
Not T, Horvath K, Hill I, Partanen J, Hammed A, Magazzu G, et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol. 1998;33(5):494-8.
Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology. 2002;122(6):1701-14.
Reeves GE, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, Wong RC, et al. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol. 2006;18(5):493-501.
Saifullah MA, Khan AA, Zahoor S, Saif S, Hashmi JS, Amer W. Prevalence of celiac disease in irritable bowel syndrome patients: A single centre experience from a large teaching hospital of Lahore, Pakistan. Journal of Fatima Jinnah Medical University. 2020;14(4):176-9.
Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Ward AM, McAlindon ME, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. The Lancet. 2001;358(9292):1504-8.
Scanlon SA, Murray JA. Update on celiac disease–etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol. 2011:297-311.
Sharma H, Verma AK, Das P, Dattagupta S, Ahuja V, Makharia GK. Prevalence of celiac disease in I ndian patients with irritable bowel syndrome and uninvestigated dyspepsia. J Dig Dis. 2015;16(8):443-8.
Sharma N, Bhatia S, Chunduri V, Kaur S, Sharma S, Kapoor P, et al. Pathogenesis of celiac disease and other gluten related disorders in wheat and strategies for mitigating them. Frontiers in Nutrition. 2020;7:6.
Shayesteh AA, Hajiani E, Hashemi SJ, Masjedizadeh A, Latifi SM, Shayesteh M. Prevalence of celiac disease in I ranian patients with irritable bowel syndrome: A cross‐sectional study. J Dig Dis. 2014;15(1):12-7.
Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, et al. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol. 2016;22(7):2242.
Wahnschaffe U, Ullrich R, Riecken E, Schulzke J. Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology. 2001;121(6):1329-38.
Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci. 2003;48:761-4.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
